What happens when a medical device cannot verify software and firmware updates?

If a device cannot verify updates, it becomes vulnerable to malicious or tampered code being installed as if it were legitimate. That creates a direct path to persistence, malfunction, or data exposure. Code signing closes that gap by letting the device check the manufacturer’s digital signature before accepting new firmware or software.

What goes wrong when update verification is missing?

When a medical device cannot verify software or firmware updates, it loses the ability to distinguish a legitimate manufacturer package from a tampered one. That turns the update channel into a trust gap: an attacker, careless intermediary, or corrupted distribution path can introduce code that the device treats as approved.

In practice, that failure changes updates from a controlled maintenance activity into a potential compromise path. The device may continue running, but its behavior, integrity, and data handling can no longer be trusted in the same way, which is why authenticated signing and verification are central to firmware safety.

Why this is a device integrity problem, not just an IT housekeeping issue

Software and firmware updates are one of the few times a device deliberately accepts new executable code. If verification is weak or absent, the update mechanism itself becomes an attack surface. That matters because the consequences are not limited to configuration drift, they can include persistence, malfunction, unsafe behavior, or exposure of sensitive clinical or operational data.

For medical devices, update trust is part of the safety boundary. A malicious payload can alter device logic, disable protections, interfere with telemetry, or create a foothold that survives reboot or routine maintenance. NIST Cybersecurity Framework 2.0 is useful here because this is fundamentally a protect-and-recover problem, the organization needs a reliable way to establish that the software being installed is the software intended.

Verification also has a lifecycle dimension. Devices that cannot validate updates are harder to patch safely, which can leave known flaws in place for longer and increase operational exposure. In a clinical environment, that often means security teams must coordinate more carefully with engineering, biomedical, and vendor support before any update process is trusted.

Why code signing and integrity checks are the control point

Code signing closes the trust gap by allowing the device to validate a digital signature before accepting new firmware or software. That verification step helps ensure the package came from the manufacturer and was not altered after signing. Without it, the device is effectively relying on transport path trust alone, which is not enough if an attacker can reach the update process.

This is also where secure access control and cryptographic trust meet. A signed update is not just a file, it is an authenticated instruction for the device to change itself. NIST SP 800-57 Key Management is relevant because the signing keys, validation keys, and their lifecycle determine whether verification is meaningful over time.

Where devices accept updates from vendors, integrators, or remote service paths, the surrounding chain matters too. NIST Privacy Framework and related security practices matter indirectly because compromised device behavior can expose protected data, but the core control remains cryptographic validation of the update itself.

Risk and Threat Considerations

When update verification is absent, the highest risk is silent compromise through a trusted maintenance path. An attacker does not need to break the device in a dramatic way, they only need a way to deliver or substitute an update package that the device will accept.

Failure mechanism: The device accepts unauthenticated or unverified code, so tampered firmware, malicious patches, or downgraded versions can be installed as though they were legitimate manufacturer updates.

Impact: The result can be persistence, device malfunction, unsafe operation, loss of integrity, or exposure of clinical or patient-related data, and the compromise may persist until the device is reimaged, replaced, or manually recovered.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST CSF 2.0, NIST SP 800-53 Rev 5 and OWASP ASVS set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.

Framework	Control / Reference	Relevance
NIST CSF 2.0	PR.DS-08 — Integrity Mechanisms	Update verification depends on integrity checks that prevent altered firmware from being accepted.
Recommendation — Require integrity checks for firmware and software updates before installation.
NIST SP 800-53 Rev 5	SI-7 — Software, Firmware, and Information Integrity	This control directly addresses verifying and protecting update integrity on devices.
	IA-5 — Authenticator Management	Signed updates rely on lifecycle management of the keys and credentials that validate trust.
Recommendation — Verify firmware and software updates before deployment and reject tampered packages. Manage signing and validation keys with rotation, protection, and revocation controls.
ISO/IEC 27001:2022	A.8.8 — Management of technical vulnerabilities	Unverified updates can leave known vulnerabilities unpatched and open to malicious code insertion.
Recommendation — Ensure update processes remove vulnerabilities without introducing untrusted code.
OWASP ASVS	V11 — Cryptography	Code signing and verification are cryptographic trust controls applied to incoming update packages.
Recommendation — Use authenticated signatures to validate update integrity before execution.

Practitioner Guidance

What to verify: Confirm that the device validates both authenticity and integrity, not just transport security. If the update process only checks that a file arrived from a vendor portal or over TLS, that is not enough if the package itself is not cryptographically verified on the device.

Decision rule: If the device cannot verify signed updates, treat the update path as untrusted until the manufacturer provides a verifiable control, such as signed firmware, rollback protection, and a documented recovery method. If those are missing, compensate with tighter network placement, change control, and vendor escalation.

What good looks like: The device should reject unsigned, tampered, or improperly signed packages, log the failure clearly, and preserve the previous known-good state. That gives operators a defensible boundary between routine maintenance and unsafe code installation.

Practitioner takeaway: For medical devices, update verification is not a convenience feature, it is the control that decides whether maintenance can become compromise.